Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1

Rieko Oyama, Fusako Kito, Marimu Sakumoto, Kumiko Shiozawa, Shunichi Toki, Makoto Endo, Akihiko Yoshida, Akira Kawai, Tadashi Kondo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.

Original languageEnglish
Pages (from-to)392-399
Number of pages8
JournalIn Vitro Cellular and Developmental Biology - Animal
Volume54
Issue number5
DOIs
Publication statusPublished - May 1 2018
Externally publishedYes

Fingerprint

Synovial Sarcoma
Proteomics
Cell Line
Microsatellite Repeats
Neoplasms
Gene Fusion
Mass Spectrometry
Research Personnel

All Science Journal Classification (ASJC) codes

  • Developmental Biology
  • Cell Biology

Cite this

Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. / Oyama, Rieko; Kito, Fusako; Sakumoto, Marimu; Shiozawa, Kumiko; Toki, Shunichi; Endo, Makoto; Yoshida, Akihiko; Kawai, Akira; Kondo, Tadashi.

In: In Vitro Cellular and Developmental Biology - Animal, Vol. 54, No. 5, 01.05.2018, p. 392-399.

Research output: Contribution to journalArticle

Oyama, Rieko ; Kito, Fusako ; Sakumoto, Marimu ; Shiozawa, Kumiko ; Toki, Shunichi ; Endo, Makoto ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi. / Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In: In Vitro Cellular and Developmental Biology - Animal. 2018 ; Vol. 54, No. 5. pp. 392-399.
@article{bb9a33e42ddb4d6c86fa9cb37078401f,
title = "Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1",
abstract = "Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.",
author = "Rieko Oyama and Fusako Kito and Marimu Sakumoto and Kumiko Shiozawa and Shunichi Toki and Makoto Endo and Akihiko Yoshida and Akira Kawai and Tadashi Kondo",
year = "2018",
month = "5",
day = "1",
doi = "10.1007/s11626-018-0237-7",
language = "English",
volume = "54",
pages = "392--399",
journal = "In Vitro Cellular and Developmental Biology - Animal",
issn = "1071-2690",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1

AU - Oyama, Rieko

AU - Kito, Fusako

AU - Sakumoto, Marimu

AU - Shiozawa, Kumiko

AU - Toki, Shunichi

AU - Endo, Makoto

AU - Yoshida, Akihiko

AU - Kawai, Akira

AU - Kondo, Tadashi

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.

AB - Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.

UR - http://www.scopus.com/inward/record.url?scp=85045066005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045066005&partnerID=8YFLogxK

U2 - 10.1007/s11626-018-0237-7

DO - 10.1007/s11626-018-0237-7

M3 - Article

C2 - 29626278

AN - SCOPUS:85045066005

VL - 54

SP - 392

EP - 399

JO - In Vitro Cellular and Developmental Biology - Animal

JF - In Vitro Cellular and Developmental Biology - Animal

SN - 1071-2690

IS - 5

ER -